| 1 | 
                
                    BRD4
                
             💬
 | - | Apabetalone 
                
                    Apabetalone
                
             💬
 | 
                
                    Apabetalone
                
             | [1]  86 86 💬
 | 
| 2 | 
                
                    BCL2
                
             💬
 | [43]  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Platinum drug resistance, NF-kappa B signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, p53 signaling pathway, Autophagy - animal, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Apoptosis, Apoptosis - multiple species, Necroptosis, Adrenergic signaling in cardiomyocytes, Hedgehog signaling pathway, Focal adhesion, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Neurotrophin signaling pathway, Cholinergic synapse, Estrogen signaling pathway, Parathyroid hormone synthesis, secretion and action, AGE-RAGE signaling pathway in diabetic complications, Amyotrophic lateral sclerosis, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Toxoplasmosis, Tuberculosis, Hepatitis B, Measles, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Pathways in cancer, MicroRNAs in cancer, Chemical carcinogenesis - receptor activation, Colorectal cancer, Prostate cancer, Small cell lung cancer, Gastric cancer, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Venetoclax 
                
                    Venetoclax
                
             💬
 | 
                
                    Venetoclax
                
             | [1]  28 28 💬
 | 
| 3 | 
                
                    BRD2
                
             💬
 | - | Apabetalone 
                
                    Apabetalone
                
             💬
 | 
                
                    Apabetalone
                
             | [1]  86 86 💬
 | 
| 4 | 
                
                    BRAF
                
             💬
 | [44]  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, MAPK signaling pathway, ErbB signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, FoxO signaling pathway, mTOR signaling pathway, Vascular smooth muscle contraction, Focal adhesion, Natural killer cell mediated cytotoxicity, Long-term potentiation, Neurotrophin signaling pathway, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Parathyroid hormone synthesis, secretion and action, Cushing syndrome, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Alcoholism, Hepatitis C, Hepatitis B, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - reactive oxygen species, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Bladder cancer, Chronic myeloid leukemia, Acute myeloid leukemia, Non-small cell lung cancer, Breast cancer, Hepatocellular carcinoma, Gastric cancer | Sorafenib 
                
                    Sorafenib
                
             💬
 | 
                
                    Sorafenib
                
             | [2]  34 34, 86 💬
 | 
| 5 | 
                
                    BRAF
                
             💬
 | [44]  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, MAPK signaling pathway, ErbB signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, FoxO signaling pathway, mTOR signaling pathway, Vascular smooth muscle contraction, Focal adhesion, Natural killer cell mediated cytotoxicity, Long-term potentiation, Neurotrophin signaling pathway, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Parathyroid hormone synthesis, secretion and action, Cushing syndrome, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Alcoholism, Hepatitis C, Hepatitis B, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - reactive oxygen species, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Bladder cancer, Chronic myeloid leukemia, Acute myeloid leukemia, Non-small cell lung cancer, Breast cancer, Hepatocellular carcinoma, Gastric cancer | Dabrafenib 
                
                    Dabrafenib
                
             💬
 | 
                
                    Dabrafenib
                
             | [1]  34 34 💬
 | 
| 6 | 
                
                    BRDT
                
             💬
 | - | Apabetalone 
                
                    Apabetalone
                
             💬
 | 
                
                    Apabetalone
                
             | [1]  86 86 💬
 | 
| 7 | 
                
                    BTK
                
             💬
 | [7]  NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Ibrutinib 
                
                    Ibrutinib
                
             💬
 | 
                
                    Ibrutinib
                
             | [3]  28 28, 60, 61 💬
 | 
| 8 | 
                
                    BTK
                
             💬
 | [7]  NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Acalabrutinib 
                
                    Acalabrutinib
                
             💬
 | 
                
                    Acalabrutinib
                
             | [2]  46 46, 61 💬
 | 
| 9 | 
                
                    BTK
                
             💬
 | [7]  NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Zanubrutinib 
                
                    Zanubrutinib
                
             💬
 | 
                
                    Zanubrutinib
                
             | [5]  13 13, 63, 222, 300, 331 💬
 | 
| 10 | 
                
                    BTK
                
             💬
 | [7]  NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Fenebrutinib 
                
                    Fenebrutinib
                
             💬
 | 
                
                    Fenebrutinib
                
             | [1]  13 13 💬
 | 
| 11 | 
                
                    BTK
                
             💬
 | [7]  NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Branebrutinib 
                
                    Branebrutinib
                
             💬
 | 
                
                    Branebrutinib
                
             | [3]  46 46, 49, 53 💬
 | 
| 12 | 
                
                    BTK
                
             💬
 | [7]  NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Orelabrutinib 
                
                    Orelabrutinib
                
             💬
 | 
                
                    Orelabrutinib
                
             | [4]  13 13, 49, 61, 63 💬
 | 
| 13 | 
                
                    BTK
                
             💬
 | [7]  NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Remibrutinib 
                
                    Remibrutinib
                
             💬
 | 
                
                    Remibrutinib
                
             | [2]  13 13, 53 💬
 | 
| 14 | 
                
                    BTK
                
             💬
 | [7]  NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency | Evobrutinib 
                
                    Evobrutinib
                
             💬
 | 
                
                    Evobrutinib
                
             | [3]  13 13, 46, 49 💬
 | 
| 15 | 
                
                    BRD3
                
             💬
 | - | Apabetalone 
                
                    Apabetalone
                
             💬
 | 
                
                    Apabetalone
                
             | [1]  86 86 💬
 |